Used for: Chronic lymphocytic leukemia (CLL/SLL) · Mantle cell lymphoma after earlier treatment · Waldenström’s macroglobulinemia · Marginal zone lymphoma that came back or didn’t respond · Follicular lymphoma that came back or didn’t respond · 4 more
How to pay the least
Ask for the cash price
Brukinsa
We didn’t find one.
What to do
Ask your pharmacy for Brukinsa’s cash price, and one or two other pharmacies too.
Compare every option
Brand name
Brukinsa, the original
Cash priceAsk the pharmacy
Ways to save on Brukinsa
The maker’s card
myBeOne Support Co-Pay Support
Savings card from BeOne Medicines
Brukinsa’s maker has a savings program. Its page doesn’t list a dollar amount.
BRUKINSA is a kinase inhibitor indicated for the treatment of adult patients with:
Mantle cell lymphoma (MCL) who have received at least one prior therapy. This indication is approved under accelerated approval based on overall response rate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial.
Waldenström's macroglobulinemia (WM).
Relapsed or refractory marginal zone lymphoma (MZL) who have received at least one anti–CD20-based regimen. This indication is approved under accelerated approval based on overall response rate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial.
Chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
Relapsed or refractory follicular lymphoma (FL), in combination with obinutuzumab, after two or more lines of systemic therapy. This indication is approved under accelerated approval based on response rate and durability of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial.
Source: the FDA label for Brukinsa (BeOne Medicines USA, Inc.), September 4, 2026. Full label on DailyMed
Good to know
“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Check the maker’s page for who can use it.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to your pharmacy.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.
Prices checked November 17, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/brukinsa/